Author Question: Honeywell International's decision to create a child-abduction prevention program _____. A) was ... (Read 122 times)

SGallaher96

  • Hero Member
  • *****
  • Posts: 509
Honeywell International's decision to create a child-abduction prevention program _____.
 
  A) was out of a desire to focus on issues related to the company's heritage.
  B) was linked to the company's child-abduction prevention products.
  C) focused on teachers as an audience that could reach children.
  D) A and B
  E) A and C

Question 2

The Got 2B Safe program ________.
 
  A) coincided with the launch of a new line of child-abduction prevention products
  B) was closely aligned with Honeywell International's mission statement
  C) featured a famous Hollywood actor as its leading spokesperson
  D) A and B
  E) B and C



Sierray

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Answer: E

Answer to Question 2

Answer: B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library